United States · FDA National Drug Code directory
Tizanidine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-902_4647720a-9159-6041-e063-6294a90a54f1
- Product NDC
- 76420-902
- Form
- CAPSULE
- Composition / generic term
- Tizanidine Hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190329
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (76420-902-01) / 10 CAPSULE in 1 BLISTER PACK · 76420-902-01
- 500 CAPSULE in 1 BOTTLE (76420-902-05) · 76420-902-05
- 10 CAPSULE in 1 BOTTLE (76420-902-10) · 76420-902-10
- 150 CAPSULE in 1 BOTTLE (76420-902-15) · 76420-902-15
- 20 CAPSULE in 1 BOTTLE (76420-902-20) · 76420-902-20
- 30 CAPSULE in 1 BOTTLE (76420-902-30) · 76420-902-30
- 60 CAPSULE in 1 BOTTLE (76420-902-60) · 76420-902-60
- 90 CAPSULE in 1 BOTTLE (76420-902-90) · 76420-902-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →